GriseofulvinThird Party Manufacturing in India
Looking to get Griseofulvin manufactured under your brand? Our WHO-GMP certified partner facilities support PCD franchise partners and global export opportunities structured across 25+ countries.
Mechanism of Action
Griseofulvin works by binding to fungal microtubules to disrupt the mitotic spindle structure during cell division. It inhibits fungal mitosis to help the body halt dermatophyte proliferation in keratinized tissues. Unlike topical alternative classes, it deposits systemically in newly keratinized skin, hair, and nails. It is highly effective and well-tolerated for stubborn superficial mycoses. Utilizing fine micronized powder conforming to CAS 126-07-8, our production facilities maximize the oral bioavailability of this hydrophobic compound.
Therapeutic Uses & Indications
Celesta Healthcare provides tailored solutions for Griseofulvin third party manufacturing in India, ensuring stable supply lines for traditional dermatological therapeutics.
Therapeutic Uses
- Tinea Capitis: Eradicates dermatophyte infections affecting the scalp and hair shafts.
- Onychomycosis: Resolves persistent fungal infections embedded within the nail bed.
Why Manufacturers Choose Griseofulvin
Despite newer azoles, this antibiotic remains irreplaceable for specific pediatric and systemic dermatophyte protocols under CAS 126-07-8. Our production facilities are WHO-GMP certified, utilizing advanced micronization technology to bypass traditional formulation challenges and deliver highly bioavailable finished products.
Dosage Forms We Manufacture
Frequently Asked Questions
What is the minimum order quantity for Griseofulvin?
What dosage forms of Griseofulvin can you manufacture?
Are your manufacturing facilities WHO-GMP certified?
Can you manufacture Griseofulvin for export?
What grade standards do you follow for Griseofulvin?
Get Griseofulvin made under your brand
- WHO-GMP certified facilities
- Quote within 24 hours
- MOQ from 10,000 tablets per batch
+91 9689237122 · replies within hours
Our Manufacturing Capabilities
- WHO-GMP Certified Partner Plants
- 25+ years of pharma industry experience
- PCD Franchise with monopoly rights
- Export support across 25+ countries
- Small batch to commercial scale
- Custom formulation development
Packaging Options
Blister pack (PVC-Alu), Secure strip packaging. Packaging customized to client brand guidelines.
Start Manufacturing Griseofulvin Today
Celesta Healthcare provides WHO-GMP certified third-party manufacturing for Griseofulvin across all dosage forms. PCD franchise and export orders welcome.